AUPH vs GOEV
Aurinia Pharmaceuticals Inc (AUPH) versus GOEV (GOEV) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
GOEV (GOEV) common stock.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
GOEV does not have a complete income-statement cache yet.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Not investment advice. Open the AUPH and GOEV stock pages for the full models.
Not investment advice.